Pfizer withdraws emergency use application for COVID-19 vaccine in India
US pharmaceutical giant Pfizer has withdrawn its application for emergency use authorization of its BNT162b2 COVID-19 vaccine in India. This decision comes after a series ... Read More
Thermo Fisher Scientific and JW Therapeutics forge strategic CAR-T therapy partnership in China
Thermo Fisher Scientific has entered into a significant agreement with Chinese cell therapy leader JW Therapeutics, granting non-exclusive commercial access to its Gibco CTS Dynabeads ... Read More
VectivBio initiates phase 3 trial of apraglutide in patients with short bowel syndrome
VectivBio, a leading Swiss biotechnology firm, has announced the commencement of patient dosing in its phase 3 STARS clinical trial. This trial will evaluate the ... Read More
Jazz Pharmaceuticals to acquire GW Pharmaceuticals in $7.2bn deal
In a significant move within the pharmaceutical industry, Irish biopharma company Jazz Pharmaceuticals has announced an agreement to acquire British-based GW Pharmaceuticals in a monumental ... Read More
Bexson Biomedical raises $4.8m to advance wearable ketamine treatment for pain and mental health disorders
Bexson Biomedical has successfully raised $4.8 million in Series A funding to accelerate the development of its subcutaneous ketamine treatment platform, aimed at revolutionizing pain ... Read More
Horizon Therapeutics announces $3.05bn acquisition of Viela Bio to expand rare disease pipeline
In a major move to strengthen its leadership in rare diseases, Horizon Therapeutics, an Irish biopharmaceutical company, has agreed to acquire Viela Bio, a US-based ... Read More
Amgen secures breakthrough therapy designation for sotorasib in China
Amgen has achieved a major milestone in the global development of its investigational KRAS G12C inhibitor, sotorasib, with the National Medical Products Administration (NMPA) in ... Read More
Nordic Capital proposes $846m acquisition of Advanz Pharma
In a significant move within the pharmaceutical industry, Nordic Capital has made a formal offer to acquire Advanz Pharma, a UK-based specialty pharmaceutical company, for ... Read More
FDA approves Opdivo and Cabometyx combo for advanced kidney cancer treatment
The U.S. Food and Drug Administration (FDA) has officially approved the combination of Bristol Myers Squibb's Opdivo (nivolumab) and Exelixis' Cabometyx (cabozantinib) for the first-line ... Read More
ViiV Healthcare’s Cabenuva secures FDA approval for HIV treatment
ViiV Healthcare has received FDA approval for Cabenuva, a long-acting treatment regimen for HIV-1 infection in adult patients. This new therapy is poised to transform ... Read More